MedPath

A single-dose study of TMS-007 in patients with ischemic stroke (phase IIa study)

Phase 2
Completed
Conditions
Acute ischemic stroke
Registration Number
JPRN-jRCT2080223786
Lead Sponsor
TMS Co., Ltd.
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
completed
Sex
All
Target Recruitment
90
Inclusion Criteria

Japanese who develop symptomatic cerebral infarction

Exclusion Criteria

1 Patients who are suitable for rt-PA or endovascular treatment
2 High bleeding risk
3 High blood pressure or high blood glucose
4 Severe disease affecting the pathology of ischemic stroke
5 Pregnancy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath